Biotech Startups

Polyphron builds a verification layer for drug discovery that combines physically engineered arrays of human tissue with AI simulations of that tissue, letting models test therapeutic predictions against living human biology. It trains frontier models to explore and reproduce human tissue biology, aiming to provide a human-relevant substrate for validating AI-generated interventions.

1 investor

Polyplus (a Sartorius company) develops FectoVIR-LV, an animal-component-free transfection reagent for producing lentiviral vectors in suspension HEK-293 cells at large manufacturing scale. It targets cell therapy producers, including those making CAR-T and other allogenic or autologous therapies, in the biomanufacturing sector.

1 investor

PolyXLabs is a biotechnology company that develops biodegradable, naturally derived polymers made from spent coffee grounds as a replacement for toxic, non-recyclable plastics for consumer goods companies. It offers customized chemical formulations for sustainable packaging and operates in the United States and Europe.

1 investor

PolyXLabs produces biodegradable plastic replacements made from spent coffee grounds and other lignocellulose-based biomass for consumer goods companies. The polymers are non-toxic, durable, and safely biodegrade without releasing microplastics.

1 investor

Ponce Aurora develops mitochondrial-targeting longevity products including a full-body treatment and energy beverages powered by MitoXcel™ technology, which addresses age-related decline in mitochondrial function. The company serves the consumer longevity and wellness market with information-based gerotherapeutics.

1 investor

Pono Tech offers Covalt, a collaborative platform for tracking loan covenants and collateral/securities with centralized data and automated reminders. It serves lenders and financing teams looking to manage credit risk and monitor their financing obligations.

1 investor

Pontifax is an investment firm that establishes and partners with biotech and healthcare companies across multiple therapeutic areas and development stages, providing hands-on portfolio management and strategic guidance.

1 investor

POP Biotechnologies develops nanomedicine platform technologies based on patented porphyrin-phospholipid (PoP) liposomes, targeting infectious disease, oncology, and chronic diseases. Its work includes a rapid vaccine development platform and targeted chemotherapy approaches activated by laser light.

1 investor

POROUS develops a non-invasive ultrasound-based medical device for quantitative bone quality assessment and osteoporosis detection. The company, spun off from Charité Universitätsmedizin Berlin, serves clinical and veterinary markets to improve bone health diagnostics and patient outcomes.

1 investor

Port Therapeutics is a company focused on cancer immunotherapy development.

1 investor

Portage is a clinical-stage immuno-oncology company developing novel cancer therapies with a portfolio in drug development. The company specializes in advancing cancer treatments through clinical development and regulatory pathways.

1 investor

Portal Innovations provides early-stage capital, laboratory space, and operational support to scientists and entrepreneurs building companies in emerging innovation ecosystems. The company connects breakthrough researchers with investors and corporate partners through deep university relationships and in-house scientific expertise.

1 investor

1 investor

Potsdam Science Park is a science and business park in the Golm district of Potsdam, Germany, hosting Max Planck and Fraunhofer institutes, University of Potsdam faculties, and research-focused companies in biotechnology, pharma, diagnostics, health, and new materials. Its site management provides services and support for scientists, students, startups, investors, and companies in the Berlin-Brandenburg region.

1 investor

Poxel is a clinical-stage biopharmaceutical company developing treatments for chronic metabolic diseases, including metabolic dysfunction-associated steatohepatitis and rare genetic disorders. The company is advancing drug candidates targeting metabolic pathways and has one approved product marketed in Japan.

1 investor

Praxis Packaging provides contract manufacturing services for pharmaceutical products, including solid dose bottling, blister packaging, liquid/cream/paste filling, and secondary packaging solutions for both prescription and over-the-counter medications in FDA and cGMP-compliant facilities.

1 investor

PRCXI manufactures laboratory equipment including oscillating incubators, shakers, and magnetic stirrers for scientific and research applications.

1 investor

PRD Therapeutics is a drug-discovery startup developing first-in-class oral SOAT2-selective inhibitors (PRD compounds derived from pyripyropene A) to regulate lipid metabolism. Its lead program targets the rare disease homozygous familial hypercholesterolemia (HoFH), with planned expansion to MASH/MASLD and other lipid-metabolism disorders.

1 investor

Precise Bio is a regenerative medicine company that develops bio-printed tissues and organs using a 4D bio-fabrication platform, initially focused on ophthalmology including a fabricated human cornea program. It serves patients with unmet medical needs that cannot be met with donor tissue, with facilities in North Carolina, USA and Shoham, Israel.

1 investor

PrecisionBiotics develops food supplements containing specific bacterial strains aimed at supporting gut health and the microbiome for consumers and clinicians, alongside educational resources on gut health. The company originated from microbiome research with the APC Microbiome Institute at UCC in Ireland and is now part of the Novonesis Group.

1 investor

Precision Chroma develops 3D-printed chromatography columns using patented technology for laboratory and analytical applications. The company is a spinoff from the University of Canterbury focused on next-generation separation and analysis equipment for the chemical and life sciences industries.

1 investor

Precision Cell Systems is a company that provides products and services related to genomics and cell/biology research, offering resources, webinars, and product ordering through its website. The available page is a privacy policy and does not describe the specific products in detail.

1 investor

PrecisionPhage develops computational and laboratory solutions for bacteriophage research to address antimicrobial resistance. The company creates bioinformatics tools and phage-based technologies intended for healthcare and biotech applications globally.

1 investor

DrugPatentWatch provides biopharmaceutical intelligence drawn from primary sources such as the USPTO, FDA Orange Book, ANDA filings, litigation records, and patent registers across 134 countries, covering drug patents, pipelines, litigation, and pricing. It serves pharmaceutical professionals including generics manufacturers, biotech firms, and distributors, offering continuously updated, exportable data for competitive and market analysis.

1 investor